跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20 条关于
“Kisquali”
全部
20
临床试验
1
药物
0
机构
0
资讯
19
3个月前
Metastatic Male Breast Cancer: A 90-Year-Old's Journey Highlights Advances in Targeted Therapy
2年前
Kisqali Demonstrates Sustained Benefit in Early Breast Cancer
2年前
Kisqali Deepens Benefit in Early Breast Cancer, Reducing Recurrence Risk by 28.5%
2年前
Kisqali Demonstrates Sustained Benefit in HR+/HER2- Early Breast Cancer
去年
Novartis' Kisqali Receives EC Approval for Early Breast Cancer Treatment
去年
Novartis Highlights Scemblix and Kisqali Data at ASH and SABCS
去年
Ribociclib (Kisqali) Gains Category 1 Recommendation for Early Breast Cancer Treatment
去年
Novartis Reports Strong Q2 2025 Results with Kisqali Leading 64% Growth Surge
2年前
Kisqali and Itovebi Secure FDA Approval for Advanced Breast Cancer Treatment
2年前
Kisqali Shows Enhanced Efficacy in Younger Breast Cancer Patients with 33% Risk Reduction
第 1 页,共 2 页
上一页
下一页